Author:
Sutaria Nilay,Sylvia Lynne,DeNofrio David
Publisher
Springer International Publishing
Reference56 articles.
1. Alloway R, Vanhaecke J, Yonan N, White M, Haddad H, Rabago G et al (2011) Pharmacokinetics in stable heart transplant recipients after conversion from twice daily to once daily tacrolimus formulations. JHLT 30:1003–1010
2. Andreassen A, Andersson B, Gustafsson F et al (2014) Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial. Am J Transplant 14:1828–1838
3. Andreassen A, Andersson B et al (2016) Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients. Three-year results from the randomized SCHEDULE trial. Am J Transplant 16:1238–1247
4. Arora S, Ueland T, Wennerblom B, Sigurdadottir V, Eiskjaer H, Botker HE et al (2011) Effect of everolimus introduction on cardiac allograft vasculopathy – results of a randomized multicenter trial. Transplantation 92:235–243
5. Arora S, Andreassen AK, Karason K, Gustafsson F, Eiskjaer H, Botker HE et al (2018) Effect of everolimus initiation and calcineurin inhibitor elimination on cardiac allograft vasculopathy in de novo heart transplant recipients: three year results of a Scandinavian randomized trial. Circ Heart Fail 11:e004050
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献